Sameer Tyagi is a notable inventor based in High Point, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on aryl and heteroaryl compounds. With a total of 3 patents, his inventions are aimed at addressing critical health issues.

Latest Patents

One of Sameer Tyagi's latest patents focuses on aryl and heteroaryl compounds, compositions, and methods of use. This invention provides a range of aryl and heteroaryl compounds, detailing methods for their preparation and pharmaceutical compositions that include these compounds. The compounds are designed to act as antagonists or partial antagonists of factor IX and/or factor XI, which may be beneficial in inhibiting the intrinsic pathway of blood coagulation. This innovation has potential applications in managing, treating, and controlling diseases linked to the intrinsic clotting pathway.

Career Highlights

Throughout his career, Sameer Tyagi has worked with Transtech Pharma, Inc., where he has further developed his expertise in pharmaceutical innovations. His work has contributed to advancements in the treatment of various disorders, showcasing his commitment to improving health outcomes.

Collaborations

Sameer has collaborated with notable professionals in his field, including Devi Reddy Gohimmukkula and Adnan M M Mjalli. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Sameer Tyagi stands out as an influential inventor in the realm of pharmaceutical compounds. His work on aryl and heteroaryl compounds demonstrates his dedication to advancing medical science and improving patient care.